PARTNER NEWS:Thu, Mar 28, 7:54 AM, Zacks
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA Syndax Pharmaceuticals (SNDX) groundbreaking menin inhibitor, revumenib, receives FDA priority review for treating relapsed, refractory acute leukemia.
Mon, Feb 26, 7:50 AM, Zacks
Syndax (SNDX) is on the Move, Here's Why the Trend Could be Sustainable Syndax (SNDX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Featured MNV Articles: See Which Of The Latest 13F Filers Holds IJR
Thursday, April 18, 12:46 PM ET, by Market News Video Staff
At Holdings Channel, we have reviewed the latest batch of the 36 most recent 13F ...
Alphabet Reports After the Close on 4/25 -- Options Contracts Expire the Next Day
Thursday, April 18, 12:08 PM ET, by Market News Video Staff
According to NextEarningsDate.com, the Alphabet (NASD: GOOG) GOOG next earnings date is projected to be ...
Arcturus Therapeutics Holdings Enters Oversold Territory (ARCT)
Thursday, April 18, 11:57 AM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Oversold Conditions For Amphastar Pharmaceuticals (AMPH)
Thursday, April 18, 11:57 AM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Equifax is Now Oversold (EFX)
Thursday, April 18, 11:53 AM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
|
|
By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
|